Cardio Agent (GW501516) – 20mg/tab – 50 tab EU Pharmaceutical
€46.00
Overview of Cardio Agent (GW501516) – 20mg/tab – 50 tab EU Pharmaceutical, history and composition
Cardio Agent, or GW501516, is a research chemical known for its performance-enhancing properties, particularly in endurance sports. Initially developed in the 1990s by GlaxoSmithKline as a potential treatment for metabolic and cardiovascular diseases, it gained traction among athletes and bodybuilders for its ability to boost physical performance. Each tablet contains 20mg of GW501516, with a total of 50 tablets per package, making it a convenient option for users looking to enhance their training regimen. Its composition includes various excipients to ensure optimal absorption and bioavailability.
Physiological impact, what happens in the body
When ingested, GW501516 activates the peroxisome proliferator-activated receptor delta (PPARδ), a crucial regulator of lipid and glucose metabolism. This activation leads to increased fatty acid oxidation and improved glucose uptake, which ultimately enhances endurance and reduces fat accumulation. As a result, users experience a significant boost in aerobic capacity, allowing for longer and more intense workouts. Moreover, GW501516 has been shown to increase the number of mitochondria in muscle cells, further optimizing energy production and stamina. This physiological impact is particularly beneficial for athletes seeking to improve performance without the negative side effects often associated with traditional stimulants.
How to acquire Cardio Agent (GW501516) – 20mg/tab – 50 tab EU Pharmaceutical, purchasing instructions
Acquiring Cardio Agent requires careful consideration, especially given its status in various jurisdictions. Many suppliers operate online, making it easier for users to access this compound. To ensure a safe purchase, look for reputable online retailers that specialize in sports supplements and research chemicals. Check customer reviews and confirm the legitimacy of the product. Additionally, ensure that the supplier can provide Certificates of Analysis, reflecting the purity and quality of the product. It’s crucial to verify the regulations in your country regarding the purchase and use of GW501516, as its legality may vary widely.
Contraindications, who should avoid it
While Cardio Agent can offer performance benefits, it is not suitable for everyone. Individuals with pre-existing health conditions, particularly those related to the liver or heart, should avoid using GW501516. Pregnant or breastfeeding women should also steer clear of this supplement, as the effects on fetal development and nursing infants are not well-studied. Additionally, individuals under the age of 18 or those with a history of substance abuse may find the risks outweigh the benefits. Consulting with a healthcare provider before starting any new supplement is highly recommended, especially if there are concerns about existing health conditions.
Key effects, main reasons for use
Athletes and fitness enthusiasts turn to Cardio Agent for several key reasons:
- Enhanced endurance and stamina, allowing for prolonged physical exertion.
- Increased fat oxidation, promoting a leaner physique.
- Improved recovery times between workouts, enabling a more rigorous training schedule.
- Boosted overall metabolic health, potentially aiding in muscle gain.
These effects make GW501516 an attractive option for those looking to push their physical limits while maintaining a high level of performance.
| Water Retention | No |
|---|---|
| Hepatotoxicity | Yes, potential liver toxicity |
| Lab Test | Detection in blood and urine tests |
| Strength | 20 mg |
| Also known as | GW-501516, Cardarine |
| Blood pressure | No significant impact |
| Trade name | Not available as a legally approved drug |
| Storage conditions | Store at room temperature, protect from light and moisture |
| Chemical name | {4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid |
| Formula | C21H18F3NO3S2 |
| Substance class | PPARОґ receptor agonist |
| Main action | Enhances fatty acid metabolism |
| Half-life | 16-24 hours |
| Dosage (medical) | Not medically approved for therapeutic use |
| Dosage (sports) | 10-20 mg per day |
| Effects | Increased endurance, fat loss, improved lipid profile |
| Side effects | Potential carcinogenic effects, liver toxicity, possible development of other cancers |
| Use in sports | Banned by major sports organizations |
| Manufacturer | Pharmaceutical |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.